Haukeland University Hospital

Running trials

• Not yet recruiting

  Reconsidering Long-Term Apirin in the Elderly in Secondary Prevention of Coronary Artery Disease Norway

  NCT07854795· Phase 4· Vestre Viken Hospital Trust· Source

• Not yet recruiting

  A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma

  NCT07728188· Phase 3· AbbVie· Source

• Recruiting

  Proton Re-irradiation in Patients With Recurrent or Second Primary Head and Neck Cancer , a Multicentre Phase II Single Arm Trial

  NCT07922967· Oslo University Hospital· Source

• Recruiting

  A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

  NCT07623200· Phase 3· Incyte Corporation· Source

• Not yet recruiting

  Patient Reported Outcomes and Different Renal Artery Clamping Techniques During Robot Assisted Kidney Resection

  NCT07853001· Bjarte Almas· Source

• Recruiting

  N-AD: Orally Administered Nicotinamide Riboside Over Two Years as a Potential Disease Modifying Treatment for Alzheimer's Disease

  NCT07741071· Phase 2· Haukeland University Hospital· Source

• Not yet recruiting

  TARGET-EBV in MS: Targeting Epstein Barr Virus with Tenofovir Alafenamide Fumarate in multiple sclerosis

  2025-522140-40-00· Phase 2· Oslo University Hospital HF· Source

• Recruiting

  Conduction System Pacing vs. Biventricular Pacing for Cardiac Resynchronization Therapy

  NCT07492979· Copenhagen University Hospital, Rigshospitalet· Source

• Recruiting

  Prospective Natural History Study of POLG Disease

  NCT07775872· The POLG Foundation· Source

• Recruiting

  eCardiacRehab - a Hybrid Patient-Centered eHealth Programme

  NCT07590635· Haukeland University Hospital· Source

• Recruiting

  Proton Versus Photon Therapy in Head and Neck Squamous Cell Carcinomas.

  NCT07580300· Phase 3· Oslo University Hospital· Source

• Recruiting

  Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma

  NCT07169344· Phase 2· Oslo University Hospital· Source

• Recruiting

  Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma.

  NCT07173972· Phase 2· Oslo University Hospital· Source

• Recruiting

  D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression

  NCT07312110· Phase 2· Haukeland University Hospital· Source

• Enrolling by invitation

  Collaboratory Treatment Pathway for Chronic Pain Patients.

  NCT07331766· St. Olavs Hospital· Source

• Recruiting

  Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

  NCT07166094· Phase 3· Genmab· Source

• Recruiting

  The Danish Bladder Cancer Group 23 Study - A European Study on Cancer in the Upper Urinary Tract

  NCT07077447· Zealand University Hospital· Source

• Not yet recruiting

  Long-term Outcomes of Patients with Rheumatoid Arthritis in Remission

  NCT06783322· Diakonhjemmet Hospital· Source

• Recruiting

  Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity

  NCT07042672· Haukeland University Hospital· Source

• Active, not recruiting

  A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy

  NCT06821542· Phase 3· Incyte Corporation· Source

• Recruiting

  Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer

  NCT06781879· Phase 4· Jakob Kristian Jakobsen· Source

• Recruiting

  Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

  NCT06801834· Phase 3· Gilead Sciences· Source

• Recruiting

  Norwegian Spontaneous Coronary Artery Dissection Study

  NCT07317323· Oslo University Hospital· Source

• Recruiting

  Thrombolysis in Factor Xa-inhibitors Trial

  NCT06878066· Phase 3· Guri Hagberg· Source

• Recruiting

  Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

  NCT06731478· Phase 3· Daiichi Sankyo· Source

• Recruiting

  Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

  NCT06419946· Phase 3· Vastra Gotaland Region· Source

• Recruiting

  Improving Diagnostics and Care After First Seizure

  NCT06814665· Haukeland University Hospital· Source

• Recruiting

  The Norwegian Immunotherapy in Multiple Myeloma Study

  NCT06855121· St. Olavs Hospital· Source

• Active, not recruiting

  Electronic Cardiac Rehabilitation (eCardiacRehab) Feasibility Study

  NCT06759805· Haukeland University Hospital· Source

• Recruiting

  Patient-centered Dosage of Levothyroxine

  NCT06455371· University Hospital of North Norway· Source

• Recruiting

  Personalized Training for People With Rare Neuromuscular Disorders

  NCT06708468· Oslo University Hospital· Source

• Recruiting

  A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer

  NCT06944587· Oslo University Hospital· Source

• Recruiting

  The Key to Integrated Trauma Treatment in Psychosis Trial

  NCT06608706· Haukeland University Hospital· Source

• Active, not recruiting

  Effect of Proactive Therapeutic Drug Monitoring on Maintenance of Sustained Disease Control in Adults With Rheumatoid Arthritis on a Subcutaneous TNF Inhibitor: The Rheumatoid Arthritis Therapeutic DRUg Monitoring Trial (RA-DRUM)

  NCT06440629· Phase 4· Diakonhjemmet Hospital· Source

• Recruiting

  RAdiotherapy With FDG-PET Guided Dose-PAINTing Compared With Standard Radiotherapy for Primary Head and Neck Cancer-3

  NCT06297902· Oslo University Hospital· Source

• Active, not recruiting

  A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative Neoplasms

  NCT06313593· Phase 1· Incyte Corporation· Source

• Recruiting

  IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

  NCT06112314· Phase 3· Immunocore Ltd· Source

• Recruiting

  Dynamic Hormone Profiling and Multimodal Data Capture in Primary Aldosteronism

  NCT06495983· Haukeland University Hospital· Source

• Recruiting

  Prophylactic Treatment With Atorvastatin for Episodic Migraine.

  NCT06248671· Phase 2· St. Olavs Hospital· Source

• Recruiting

  Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig)

  NCT06485336· Phase 2· St. Olavs Hospital· Source

• Recruiting

  The Lumbar Interbody Fusion vs. Multidisciplinary Rehabilitation (LIFEHAB) Trial

  NCT06169488· Oslo University Hospital· Source

• Recruiting

  The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism

  NCT06162013· Phase 2· Haukeland University Hospital· Source

• Active, not recruiting

  Donor Selection for Faecal Microbiota Transplantation in Irritable Bowel Syndrome

  NCT06171126· Haukeland University Hospital· Source

• Recruiting

  Exercise Training Study of Patients With Claudicatio Intermittens

  NCT06448390· Norwegian University of Science and Technology· Source

• Active, not recruiting

  Digital Treatment of Irritable Bowel Syndrome (IBS)

  NCT06117865· Haukeland University Hospital· Source

• Recruiting

  Exercise Therapy in Mental Disorders-study

  NCT06313918· Haukeland University Hospital· Source

• Recruiting

  NOAC9 - Circulating Tumor DNA Guided Follow-Up in Anal Cancer

  NCT05572801· Aarhus University Hospital· Source

• Recruiting

  Total Neoadjuvant Treatment Combined With Adaptive Radiotherapy for Rectal Cancer

  NCT05883800· Haukeland University Hospital· Source

• Active, not recruiting

  PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway

  NCT05852873· Phase 3· Haukeland University Hospital· Source

• Recruiting

  Nicotinamide Riboside Supplementation In Progressive Multiple Sclerosis

  NCT05740722· Phase 2· Haukeland University Hospital· Source

Showing 50 of 102.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers5 recruiting
• Coronary artery disease4 recruiting
• Multiple sclerosis4 recruiting
• Sarcoma4 recruiting
• Bladder cancer3 recruiting
• Head and neck cancer3 recruiting
• ALS (motor neurone disease)2 recruiting
• Atrial fibrillation2 recruiting
• Cushing's syndrome2 recruiting
• Epilepsy2 recruiting
• Kidney cancer2 recruiting
• Migraine2 recruiting
• Multiple myeloma2 recruiting
• Pancreatic cancer2 recruiting
• Schizophrenia2 recruiting
• Stroke2 recruiting
• Acute myeloid leukaemia1 recruiting
• Alzheimer disease1 recruiting
• Amyloidosis1 recruiting
• Asthma1 recruiting
• Autism1 recruiting
• Bipolar disorder1 recruiting
• Charcot-Marie-Tooth disease1 recruiting
• Colorectal cancer1 recruiting
• Depression1 recruiting
• Endometrial cancer1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Glioblastoma1 recruiting
• Graves' disease and hyperthyroidism1 recruiting
• Heart failure1 recruiting
• Hypothyroidism1 recruiting
• Insomnia1 recruiting
• Lung cancer1 recruiting
• Melanoma1 recruiting
• Metastatic breast cancer1 recruiting
• Multiple system atrophy1 recruiting
• Myelodysplastic syndromes1 recruiting
• Myeloproliferative neoplasms1 recruiting
• Neuroblastoma1 recruiting
• Obesity1 recruiting
• Osteoarthritis1 recruiting
• Parkinson disease1 recruiting
• Peripheral artery disease1 recruiting
• Psoriasis1 recruiting
• Psoriatic arthritis1 recruiting
• Rheumatoid arthritis1 recruiting
• Thyroid cancer1 recruiting

Closed trials

• Completed

  Efficacy and Safety Study of HRO350 in Patients with Mild-to-moderate Psoriasis (the 'HeROPA' Study).

  NCT06125808· Phase 2· Arctic Bioscience· Source

• Completed

  Feasibility of a Life Coping Program: A Study Protocol

  NCT06709248· Haukeland University Hospital· Source

• Completed

  Oral Appliances With and Without Elastic Bands to Treat Obstructive Sleep Apnea: A Randomized Crossover Trial

  NCT05987618· University of Bergen· Source

• Completed

  N-DOSE: A Dose Optimization Trial of Nicotinamide Riboside in Parkinson's Disease

  NCT05589766· Phase 2· Haukeland University Hospital· Source

• Completed

  N-DOSE AD: A Dose Optimization Trial of Nicotinamide Riboside in Alzheimer's Disease

  NCT05617508· Phase 2· Haukeland University Hospital· Source

• Completed

  Happy Hands - an E-self-management Intervention for People With Hand Osteoarthritis

  NCT05568875· Diakonhjemmet Hospital· Source

• Completed

  A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321069· Phase 3· Boehringer Ingelheim· Source

• Completed

  Aiming Towards Evidence Based Interpretation of Cardiac Biomarkers in Patients Presenting With Chest Pain Using Point of Care Assays

  NCT05354804· Haukeland University Hospital· Source

• Completed

  10-year Follow-up of Patients With Rheumatoid Arthritis Who Received Structured Treat-to-target Therapy in Early Disease

  NCT05304013· Diakonhjemmet Hospital· Source

• Completed

  A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial

  NCT04876391· Phase 2· Boehringer Ingelheim· Source

• Terminated

  Open-Label Surufatinib in European Patients With NET

  NCT04579679· Phase 2· Hutchmed· Source

• Terminated

  To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)

  NCT04551053· Phase 3· Incyte Corporation· Source

• Terminated

  To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)

  NCT04551066· Phase 3· Incyte Corporation· Source

• Active, not recruiting

  A Study to Evaluate the Safety and Activity of Belvarafenib as a Single Agent and in Combination With Either Cobimetinib or Cobimetinib Plus Nivolumab in Patients With NRAS-mutant Advanced Melanoma.

  NCT04835805· Phase 1· Genentech, Inc.· Source

• Completed

  Combined PSMA PET/MRI for Detection of Lymph Node Metastases in High-risk Prostate Cancer Patients

  NCT04790968· Norwegian University of Science and Technology· Source

• Completed

  Internet-delivered Intervention Targeting Residual Cognitive Symptoms After Major Depressive Disorder

  NCT04864353· Haukeland University Hospital· Source

• Completed

  Candesartan for Migraine Prevention:

  NCT04574713· Phase 2· St. Olavs Hospital· Source

• Terminated

  Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors

  NCT04272034· Phase 1· Incyte Corporation· Source

• Completed

  A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype

  NCT04718389· Phase 3· GlaxoSmithKline· Source

• Completed

  Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).

  NCT04472429· Phase 3· Incyte Corporation· Source

• Completed

  Inducible Laryngeal Obstruction in Severe Asthma in Severe Asthma

  NCT04593394· Haukeland University Hospital· Source

• Completed

  A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes

  NCT04560998· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Randomized Controlled Trial of Nicotinamide Riboside Supplementation in Early Parkinson's Disease

  NCT03568968· Phase 3· Haukeland University Hospital· Source

• Withdrawn

  Trial Comparing Niraparib-bevacizumab-Dostarlimab and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian Cancer

  NCT03806049· Phase 3· Nordic Society of Gynaecological Oncology - Clinical Trials Unit· Source

• Completed

  A Multidisciplinary Intervention in Total Knee Arthroplasty

  NCT03771430· Lovisenberg Diakonale Hospital· Source

• Completed

  A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis

  NCT03646604· Phase 1· AbbVie· Source

• Completed

  Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix

  NCT03556839· Phase 3· Grupo Español de Investigación en Cáncer de Ovario· Source

• Terminated

  Efficacy and Safety of Thrombectomy in Stroke With Extended Lesion and Extended Time Window

  NCT03094715· University Hospital Heidelberg· Source

• Completed

  METIMMOX: Colorectal Cancer METastasis - Shaping Anti-tumor IMMunity by OXaliplatin

  NCT03388190· Phase 2· University Hospital, Akershus· Source

• Withdrawn

  The Diabetes Patient-Reported Outcome Measures Trial

  NCT03471104· Haukeland University Hospital· Source

• Terminated

  "Watch and Wait" After Neo-adjuvant Chemoradiotherapy for Primary Locally Advanced Rectal Cancer.

  NCT03402477· Helse Stavanger HF· Source

• Completed

  Aspirin in Colorectal Cancer Liver Metastases

  NCT03326791· Phase 2/3· Oslo University Hospital· Source

• Completed

  A Study of Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy

  NCT03069352· Phase 3· AbbVie· Source

• Completed

  Integrated Treatment of Hepatitis C Virus Infection

  NCT03155906· Haukeland University Hospital· Source

• Completed

  Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Prospective Cohort Study

  NCT03578796· Haukeland University Hospital· Source

• Completed

  BGB324 in Combination With Pembrolizumab or Dabrafenib/Trametinib in Metastatic Melanoma

  NCT02872259· Phase 1/2· Haukeland University Hospital· Source

• Completed

  Dynamic Hormone Diagnostics in Endocrine Disease

  NCT02934399· Haukeland University Hospital· Source

• Completed

  A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer

  NCT02163694· Phase 3· AbbVie· Source

• Completed

  Hypofractionated Radiotherapy With Magnetic Resonance Imaging-Guided Focal Boost and Pelvic Irradiation in High-Risk Prostate Cancer

  NCT07900555· Phase 2· Haukeland University Hospital· Source

• Terminated

  Adrenalectomy Versus Follow-up in Patients With Subclinical Cushings Syndrome

  NCT01246739· Region Skane· Source

• Completed

  Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma

  NCT01208766· Phase 3· Stichting Hemato-Oncologie voor Volwassenen Nederland· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Insomnia23 works · 1 trial
• Myasthenia gravis14 works · 0 trials
• Irritable bowel syndrome11 works · 2 trials
• Fabry disease5 works · 0 trials